Myocardial Perfusion Imaging Modalities: What do we Really see?
https://doi.org/10.18087/cardio.2017.7.10000
Abstract
Assessment of perfusion, severity of ischemia and the volume of viable myocardium, including single-photon or positron emission tomography (SPECT and PET ) is one of the most important stages of examination of patients with ischemic heart disease. However, in recent years “perfusion” prefix was added to other cardiologic modalities (echocardiography, magnetic resonance and computed tomography). Such a terminological uncertainty leads cardiologists to an erroneous evaluation of real possibilities of these methods. The review clarifies the definitions of terms “perfusion”, “ischemia”, and “viability” of the myocardium. Imaging modalities are compared from the perspective of compliance with the kinetics of the indicators used and actually visualized myocardial processes.
Keywords
About the Authors
A. A. Ansheles
Russian Cardiology Research and Production Complex
Russian Federation
Russian Federation
V. B. Sergienko
Russian Cardiology Research and Production Complex
Russian Federation
Russian Federation
References
1. Montalescot G., Sechtem U., Achenbach S. et al. 2013 ESC guidelines on the management of stable coronary artery disease: the Task Force on the management of stable coronary artery disease of the European Society of Cardiology. Eur Heart J 2013;34(38):2949-3003.
2. Le Bihan D., Turner R. The capillary network: a link between IVIM and classical perfusion. Magn Reson Med 1992;27(l):171-178.
3. Schmitt F., Stehling M.K., Turner R. Echo-Planar Imaging: Theory, Technique and Application. Springer, 1998.
4. Schneider M. Characteristics of SonoVuetrade mark. Echocardiography 1999;16(7, Pt 2):743-746.
5. Saeed M., Hetts S.W., Jablonowski R., Wilson M.W. Magnetic resonance imaging and multi-detector computed tomography assessment of extracellular compartment in ischemic and non-ischemic myocardial pathologies. World J Cardiol 2014;6(11):1192-1208.
6. McKillop J.H. Thallium 201 scintigraphy. West J Med 1980;133(1):26-43.
7. Boden W. E., O'Rourke R. A., Teo K. K. et al. Optimal medical therapy with or without PCI for stable coronary disease. N Engl J Med 2007;356(15):1503-1516.
8. Hachamovitch R., Hayes S.W., Friedman J.D. et al. Comparison of the short-term survival benefit associated with revascularization compared with medical therapy in patients with no prior coronary artery disease undergoing stress myocardial perfusion single photon emission computed tomography. Circulation 2003;107(23):2900-2907.
9. Hachamovitch R., Di Carli M.F. Methods and limitations of assessing new noninvasive tests: Part II: Outcomes-based validation and reliability assessment of noninvasive testing. Circulation 2008;117(21):2793-2801.
10. Tonino P. A., De Bruyne B., Pijls N. H. et al. Fractional flow reserve versus angiography for guiding percutaneous coronary intervention. N Engl J Med 2009;360(3):213-224.
11. Majmudar M.D., Nahrendorf M. Cardiovascular molecular imaging: the road ahead. J Nucl Med 2012;53(5):673-676.
12. Sato A., Hiroe M., Tamura M. et al. Quantitative measures of coronary stenosis severity by 64-Slice CT angiography and relation to physiologic significance of perfusion in nonobese patients: comparison with stress myocardial perfusion imaging. J Nucl Med 2008;49(4):564-572.
13. van Nunen L. X., Zimmermann F. M., Tonino P. A. et al. Fractional flow reserve versus angiography for guidance of PCI in patients with multivessel coronary artery disease (FAME): 5-year follow-up of a randomised controlled trial. Lancet 2015;386(10006):1853-1860.
14. Johnson N. P., Gould K. L. Fractional Flow Reserve Returns to Its Origins: Quantitative Cardiac Positron Emission Tomography. Circ Cardiovasc Imaging 2016;9(9).
15. Windecker S., Kolh P., Alfonso F. et al. 2014 ESC/EACTS Guidelines on myocardial revascularization: The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS) Developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions (EAPCI). Eur Heart J 2014;35(37):2541-2619.
16. Gibbons R.J., Hodge D.O., Berman D.S. et al. Long-term outcome of patients with intermediate-risk exercise electrocardiograms who do not have myocardial perfusion defects on radionuclide imaging. Circulation 1999;100(21):2140-2145.
17. Bonow R.O., Maurer G., Lee K.L. et al. Myocardial viability and survival in ischemic left ventricular dysfunction. N Engl J Med 2011;364(17):1617-1625.
18. Гуля М.О., Лишманов Ю.Б., Завадовский К.В., Лебедев Д.И. Состояние метаболизма жирных кислот в миокарде левого желудочка и прогноз эффективности кардиоресинхронизирующей терапии у пациентов с дилатационной кардиомиопатией. Российский кардиологический журнал 2014;113(9):61-67)
19. Ghosh N., Rimoldi O.E., Beanlands R.S., Camici P.G. Assessment of myocardial ischaemia and viability: role of positron emission tomography. Eur Heart J 2010;31(24):2984-2995
20. Лишманов Ю.Б., Ефимова И.Ю., Чернов В.И. и др. Сцинтиграфия как инструмент диагностики, прогнозирования и мониторинга лечения болезней сердца. Сибирский медицинский журнал 2007;22(3):74-77)
21. Сергиенко В.Б., Аншелес А.А. Томографические методы в оценке перфузии миокарда. Вестник рентгенологии и радиологии 2010;3:10-14
22. Shrestha U., Sciammarella M., Alhassen F. et al. Measurement of absolute myocardial blood flow in humans using dynamic cardiac SPECT and 99mTc-tetrofosmin: Method and validation. J Nucl Cardiol 2017; 24(1):268-277
23. Мочула А.В., Завадовский К.В., Лишманов Ю.Б. Методика определения резерва миокардиального кровотока с использованием нагрузочной динамической однофотонной эмиссионной компьютерной томографии. Бюллетень экспериментальной биологии и медицины 2015;160(12):845-848
24. Husmann L., Herzog B.A., Gaemperli O., et al. Diagnostic accuracy of computed tomography coronary angiography and evaluation of stress-only single-photon emission computed tomography/ computed tomography hybrid imaging: comparison of prospective electrocardiogram-triggering vs. retrospective gating. Eur Heart J 2009;30(5):600-607.
25. Florian A., Jurcut R., Ginghina C., Bogaert J. Cardiac magnetic resonance imaging in ischemic heart disease: a clinical review. J Med Life 2011;4(4):330-345.
26. Hulten E., Ahmadi A., Blankstein R. CT Assessment of Myocardial Perfusion and Fractional Flow Reserve. Prog Cardiovasc Dis 2015;57(6):623-631.
27. Lee J.H., Han D., Danad I. et al. Multimodality Imaging in Coronary Artery Disease: Focus on Computed Tomography. J Cardiovasc Ultrasound 2016;24(1):7-17.
28. Bamberg F., Marcus R.P., Becker A. et al. Dynamic myocardial CT perfusion imaging for evaluation of myocardial ischemia as determined by MR imaging. JACC Cardiovasc Imaging 2014;7(3):267-277.
29. Pesenti-Rossi D., Peyrou J., Baron N., et al. Cardiac MRI: technology, clinical applications, and future directions. Ann Cardiol Angeiol (Paris) 2013;62(5):326-341.
30. Аншелес А.А., Шульгин Д.Н., Соломяный В.В., Сергиенко В.Б. Сопоставление результатов нагрузочных проб, данных однофотонной эмиссионной компьютерной томографии миокарда и коронарографии у больных ишемической болезнью сердца. Кардиологический вестник 2012;2:10-17
31. Аншелес А.А., Шульгин Д.Н., Соломяный В.В., Сергиенко В.Б. Сопоставление результатов нагрузочных проб, данных однофотонной эмиссионной компьютерной томографии миокарда и коронарографии у больных ишемической болезнью сердца. Кардиологический вестник 2012;2:10-17
32. Сергиенко В. Б., Саютина Е. В., Самойленко Л. Е. и др. Роль дисфункции эндотелия в развитии ишемии миокарда у больных ишемической болезнью сердца с неизмененными и малоизмененными коронарными артериями. Кардиология 1999;39(1):25-30
Review
For citations:
Ansheles A.A., Sergienko V.B. Myocardial Perfusion Imaging Modalities: What do we Really see? Kardiologiia. 2017;57(7):5-12. https://doi.org/10.18087/cardio.2017.7.10000
Views:
9742
Email this article 
Post a Comment 
